ArticleAdvances in therapy2025

LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area.

Liming Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.